Global Pharmaceuticals & Biotech Most Popular Stocks

NextCure

Market Cap: US$15.5m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

Plumbline Life Sciences

Market Cap: ₩21.7b

Engages in the development and sale of DNA medicines for animals.

Minerva Neurosciences

Market Cap: US$15.1m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Athira Pharma

Market Cap: US$15.0m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

BioCardia

Market Cap: US$15.0m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Silco Pharmaceuticals

Market Cap: ৳1.8b

Engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally.

OptiBiotix Health

Market Cap: UK£11.1m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

Bal Pharma

Market Cap: ₹1.3b

Manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

Moogene Medi

Market Cap: ₩20.9b

Develops gene therapies based on its proprietary gene-editing platform technology.

Denis Chem Lab

Market Cap: ₹1.3b

A pharmaceutical company, engages in the manufacturing and marketing of sterile intravenous injectable products for human and veterinary use in India.

Valbiotis

Market Cap: €12.6m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

EXACT Therapeutics

Market Cap: NOK 145.5m

A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).

Medicofarma Biotech

Market Cap: zł53.2m

A biotechnology company, provides medicines, medicinal products, and biotechnology products.

Lipocine

Market Cap: US$14.5m

A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.

Par Drugs and Chemicals

Market Cap: ₹1.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

Libra Infusions

Market Cap: ৳1.8b

Manufactures and sells injectable intravenous fluids in Bangladesh.

Leap Therapeutics

Market Cap: US$14.3m

A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

ProBiotix Health

Market Cap: UK£10.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

AlphaTON Capital

Market Cap: US$14.2m

A clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.

Sotac Pharmaceuticals

Market Cap: ₹1.3b

Engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Predilife

Market Cap: €12.1m

Designs and markets predictive tests for the occurrence of serious illnesses.

Can-Fite BioPharma

Market Cap: ₪47.3m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

Silva Pharmaceuticals

Market Cap: ৳1.7b

Engages in manufacture and marketing of pharmaceutical products in Bangladesh and internationally.

Dextech Medical

Market Cap: SEK 132.2m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

BiomX

Market Cap: US$13.8m

A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.

Otsuka Pakistan

Market Cap: PK₨3.9b

Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.

Pharma-Bio Serv

Market Cap: US$13.8m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Vivesto

Market Cap: SEK 129.1m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

Oncoinvent

Market Cap: NOK 136.8m

A clinical stage company, develops radiopharmaceutical therapies against cancer.

BioVie

Market Cap: US$13.6m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 127.4m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Avecho Biotechnology

Market Cap: AU$20.6m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Futura Medical

Market Cap: UK£10.0m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

Immuron

Market Cap: AU$20.4m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Nirman Agri Genetics

Market Cap: ₹1.2b

Operates as an agri-input company in India.

Alzinova

Market Cap: SEK 125.2m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.